Kanagawa, Japan

Noritoshi Sano


Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Kawasaki, JP (1983)
  • Kanagawa, JP (1992)

Company Filing History:


Years Active: 1983-1992

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Exploring the Innovations of Noritoshi Sano

Introduction

Noritoshi Sano is an esteemed inventor based in Kanagawa, Japan, recognized for his contributions to the field of pharmaceuticals. With a focus on developing novel compounds, Sano has secured a total of two patents that reflect his dedication to advancing medical science and addressing health challenges.

Latest Patents

Sano's latest innovations include the development of novel vitamin E derivatives, specifically designed to provide an excellent antihyperlipemic effect. The formulation, defined by a specific formula, signifies his commitment to enhancing health through scientific research. Additionally, he has created an anticoagulant product that incorporates heparin with low affinity for antithrombin III, aiming to improve patient outcomes in blood coagulation treatment.

Career Highlights

Throughout his career, Sano has made significant strides in the pharmaceutical industry, primarily through his work at Eisai Company, Limited. His research efforts have led to breakthrough inventions that continue to impact the medical community positively.

Collaborations

At Eisai Company, Limited, Sano collaborates with fellow innovators, including Suguru Suzuki and Tetsuya Tajima. These partnerships foster a dynamic environment for creativity and innovation, allowing them to combine their expertise and explore new avenues in pharmaceutical development.

Conclusion

Noritoshi Sano's contributions to the world of science and medicine underscore the importance of innovation in improving health outcomes. His patents on vitamin E derivatives and anticoagulants reflect a deep understanding of medical needs and a commitment to contributing positively to society through his work in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…